Mechanism of HIV reverse transcriptase inhibition by zinc: formation of a highly stable enzyme-(primer-template) complex with profoundly diminished catalytic activity

J Biol Chem. 2011 Nov 25;286(47):40433-42. doi: 10.1074/jbc.M111.289850. Epub 2011 Sep 26.

Abstract

Several physiologically relevant cations including Ca(2+), Mn(2+), and Zn(2+) have been shown to inhibit HIV reverse transcriptase (RT), presumably by competitively displacing one or more Mg(2+) ions bound to RT. We analyzed the effects of Zn(2+) on reverse transcription and compared them to Ca(2+) and Mn(2+). Using nucleotide extension efficiency as a readout, Zn(2+) showed significant inhibition of reactions with 2 mM Mg(2+), even when present at only ∼5 μM. Mn(2+) and Ca(2+) were also inhibitory but at higher concentrations. Both Mn(2+) and Zn(2+) (but not Ca(2+)) supported RT incorporation in the absence of Mg(2+) with Mn(2+) being much more efficient. The maximum extension rates with Zn(2+), Mn(2+), and Mg(2+) were ∼0.1, 1, and 3.5 nucleotides per second, respectively. Zinc supported optimal RNase H activity at ∼25 μM, similar to the optimal for nucleotide addition in the presence of low dNTP concentrations. Surprisingly, processivity (average number of nucleotides incorporated in a single binding event with enzyme) during reverse transcription was comparable with Zn(2+) and Mg(2+), and single RT molecules were able to continue extension in the presence of Zn(2+) for several hours on the same template. Consistent with this result, the half-life for RT-Zn(2+)-(primer-template) complexes was 220 ± 60 min and only 1.7 ± 1 min with Mg(2+), indicating ∼130-fold more stable binding with Zn(2+). Essentially, the presence of Zn(2+) promotes the formation of a highly stable slowly progressing RT-(primer-template) complex.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Avian Myeloblastosis Virus / enzymology
  • Biocatalysis / drug effects*
  • Calcium / pharmacology
  • DNA Primers / metabolism*
  • Deoxyribonucleotides / metabolism
  • Dose-Response Relationship, Drug
  • Enzyme Stability / drug effects
  • HIV Reverse Transcriptase / antagonists & inhibitors*
  • HIV Reverse Transcriptase / chemistry
  • HIV Reverse Transcriptase / genetics
  • HIV Reverse Transcriptase / metabolism*
  • HIV-1 / drug effects
  • HIV-1 / enzymology*
  • HIV-1 / genetics
  • HIV-1 / physiology
  • Kinetics
  • Magnesium / pharmacology
  • Moloney murine leukemia virus / enzymology
  • Mutation
  • Reverse Transcriptase Inhibitors / pharmacology*
  • Ribonuclease H, Human Immunodeficiency Virus / antagonists & inhibitors
  • Ribonuclease H, Human Immunodeficiency Virus / chemistry
  • Ribonuclease H, Human Immunodeficiency Virus / metabolism
  • Templates, Genetic
  • Virus Replication / drug effects
  • Zinc / pharmacology*

Substances

  • DNA Primers
  • Deoxyribonucleotides
  • Reverse Transcriptase Inhibitors
  • HIV Reverse Transcriptase
  • Ribonuclease H, Human Immunodeficiency Virus
  • Magnesium
  • Zinc
  • Calcium